| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 4900 | 2020 |
| Compassionate use of remdesivir for patients with severe Covid-19 J Grein, N Ohmagari, D Shin, G Diaz, E Asperges, A Castagna, T Feldt, ... New England Journal of Medicine 382 (24), 2327-2336, 2020 | 3004 | 2020 |
| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2362 | 2020 |
| Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells S Matsuyama, N Nao, K Shirato, M Kawase, S Saito, I Takayama, ... Proceedings of the National Academy of Sciences 117 (13), 7001-7003, 2020 | 1192 | 2020 |
| Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development M Imai, K Iwatsuki-Horimoto, M Hatta, S Loeber, PJ Halfmann, ... Proceedings of the National Academy of Sciences 117 (28), 16587-16595, 2020 | 833 | 2020 |
| ACTT-1 Study Group Members JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... Remdesivir for the treatment of Covid-19—final report. N Engl J Med 383 (19 …, 2020 | 275 | 2020 |
| Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (10), 995-998, 2022 | 263 | 2022 |
| Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 S Kutsuna, Y Kato, T Takasaki, ML Moi, A Kotaki, H Uemura, T Matono, ... Eurosurveillance 19 (4), 2014 | 221 | 2014 |
| The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner M Yamamoto, M Kiso, Y Sakai-Tagawa, K Iwatsuki-Horimoto, M Imai, ... Viruses 12 (6), 629, 2020 | 206 | 2020 |
| Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug … K Matsumoto, Y Takesue, N Ohmagari, T Mochizuki, H Mikamo, M Seki, ... Journal of Infection and Chemotherapy 19, 365-380, 2013 | 205 | 2013 |
| Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae T Miyoshi-Akiyama, K Hayakawa, N Ohmagari, M Shimojima, T Kirikae PloS one 8 (6), e66358, 2013 | 203 | 2013 |
| Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2 E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ... New England Journal of Medicine 386 (15), 1475-1477, 2022 | 199 | 2022 |
| Autochthonous dengue fever, tokyo, japan, 2014 S Kutsuna, Y Kato, ML Moi, A Kotaki, M Ota, K Shinohara, T Kobayashi, ... Emerging infectious diseases 21 (3), 517, 2015 | 185 | 2015 |
| Novel SARS-CoV-2 variant in travelers from Brazil to Japan T Fujino, H Nomoto, S Kutsuna, M Ujiie, T Suzuki, R Sato, T Fujimoto, ... Emerging infectious diseases 27 (4), 1243, 2021 | 175 | 2021 |
| First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics S Saito, Y Asai, N Matsunaga, K Hayakawa, M Terada, H Ohtsu, ... Journal of Infection 82 (4), 84-123, 2021 | 170 | 2021 |
| Clinical epidemiology of hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan: report of the COVID-19 registry Japan N Matsunaga, K Hayakawa, M Terada, H Ohtsu, Y Asai, S Tsuzuki, ... Clinical Infectious Diseases 73 (11), e3677-e3689, 2021 | 165 | 2021 |
| Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA. 2 R Uraki, M Kiso, S Iida, M Imai, E Takashita, M Kuroda, PJ Halfmann, ... Nature 607 (7917), 119-127, 2022 | 139 | 2022 |
| Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urine K Shinohara, S Kutsuna, T Takasaki, ML Moi, M Ikeda, A Kotaki, ... Journal of travel medicine 23 (1), 2016 | 130 | 2016 |
| Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis R Matsuyama, H Nishiura, S Kutsuna, K Hayakawa, N Ohmagari BMC public health 16 (1), 1-10, 2016 | 128 | 2016 |
| Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancer N Ohmagari, H Hanna, L Graviss, B Hackett, C Perego, V Gonzalez, ... Cancer 104 (1), 205-212, 2005 | 126 | 2005 |
